female
repro
mammary carcinoma
• Incidence increases, but results of mammograhy did not prove
• Association: PCDD/F (policlorinated dibenzo-dioxines
and dibenzo-furanes), PCB-s, solvents
• Association: CYP polymorphisms
• Association: therapeautical estrogenes (hormone-replacement),
DES
• Association: total internal estrogen load
• Association: DDE/DDT and other esztrogen-like chlorinated
chemicals
• Proof: early life
stages are critical
|
|
|
endocrine-based
infertility
(2nd Departement of
Gynaecology and Obstretics,
Semmelweis University,
Medical School, Budapest)
1970's frequency: 2.7-2.9% |
2010's frequency: 12-15%(!) |
17b-estradiol (E2) |
ethinylestradiol 60x
more active than E2 |
bioligically degrades (metabolized) |
no metabolic degradation |
|
|